Search clinical trials for: VPD-737

Total 2369 results

Imperial College London
Wellcome Trust

Completed

The Development of a Human Model of Respiratory Syncytial Virus Infection

Respiratory Syncytial Virus Infections | Respiratory Viral Infections

United Kingdom
Vyne Therapeutics Inc.

Completed

VPD-737 for Treatment of Chronic Pruritus

Chronic Pruritus

United States
Jean Yuh Tang
Vyne Therapeutics Inc.; Epidermolysis Bullosa Research Partnership

Completed

Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients

Pruritus | Epidermolysis Bullosa

United States
Vyne Therapeutics Inc.

Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

Prurigo Nodularis

Germany
United States Army Research Institute of Environmental...
US Army Research and Development Command- Soldier Center

Completed

Effects of Energy and Physical Density Manipulation on Appetite

Eating Behavior | Appetite

United States
Vyne Therapeutics Inc.

Terminated

Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)

Psoriasis | Pruritus | Atopic Dermatitis | Prurigo Nodularis

United States, Austria, Germany, Poland
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Pruritus | Prurigo Nodularis

Austria, Germany, Poland
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis

Pruritus | Prurigo Nodularis

United States
Stanford University
Epidermolysis Bullosa Research Partnership; Menlo Therapeutics

Completed

A Neurokinin-1 Receptor Antagonist for the Treatment of Pruritus in Patients With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin

Pruritus

United States
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Refractory Chronic Cough

United States, United Kingdom
Vyne Therapeutics Inc.

Completed

Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis

Psoriasis | Pruritus

United States
Samsung Medical Center

Recruiting

Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study

Breast Cancer Lymphedema

Korea, Republic of
Takeda

Withdrawn

A Phase 1, Single and Multiple Dose Study of TAK-137

Healthy Japanese Adult Male

Japan
Siemens Molecular Imaging

Completed

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037 (VM4-037)

Renal Cell Carcinoma | Head and Neck Cancer | Lung Cancer | Squamous Cell Carcinoma | Hepatic Carcinoma

United States
Concert Pharmaceuticals

Completed

A Safety and Tolerability Study of CTP-730 in Healthy Volunteers

Healthy

Australia
Takeda

Terminated

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.

Attention-Deficit/Hyperactivity Disorder

United States
Azienda Sanitaria ASL Avellino 2

Unknown

Very Low Protein Diet and Renal Death in Chronic Kidney Disease (CKD)-ERIKA Study

Chronic Renal Insufficiency

Italy
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
MiNK Therapeutics

Completed

Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2

Respiratory Distress Syndrome, Adult

United States
Amgen

Completed

A Phase 1/2 Study Evaluating AMG 337 in Asian Subjects

Stomach Neoplasms

Japan
Traslational Cancer Drugs Pharma, SL

Completed

Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

United States
ArQule, Inc. (a wholly owned subsidiary of Merck...

Completed

Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations

Solid Tumor

United States, Italy
Sosei

Completed

A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia

Fibromyalgia

United Kingdom
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors.

Neoplasms | Tumors

United States
AbbVie

Recruiting

Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia

United States, Israel, Japan, Australia, Korea, Republic of
Shanghai Hengrui Pharmaceutical Co., Ltd.

Recruiting

A Trial of SHR-7367 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

China
Fochon Pharmaceuticals, Ltd.

Completed

Study of FCN-437c in Patients With Advanced Solid Tumors (FCN-437c)

Solid Tumor, Adult

United States
Gilead Sciences

Terminated

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

Chronic Obstructive Pulmonary Disease | Cystic Fibrosis

United States
Millennium Pharmaceuticals, Inc.

Completed

Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

Advanced Metastatic Melanoma | Advanced Non-hematologic Malignancies

United States
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Healthy Volunteers

Drug Safety

United States
Sun Pharma Advanced Research Company Limited

Completed

Evaluation of Efficacy and Safety of SDN-037

Inflammation and Pain Associated With Ocular Surgery

United States
Flex Pharma, Inc.

Terminated

Study to Evaluate Safety & Efficacy of FLX-787-ODT to Treat Fasciculations in Tongue and Appendicular Muscle in Adult Subjects With ALS

Amyotrophic Lateral Sclerosis | Fasciculation

United States
Amgen

Terminated

20101299: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms

Schizophrenia

United States, Canada, Spain, Australia, New Zealand, Russian Federation, Singapore
Amgen

Terminated

20110165: Study to Evaluate the Effect of AMG 747 on Schizophrenia Negative Symptoms (Study 165)

Schizophrenia

United States, France, United Kingdom, Malaysia, Poland, Czech Republic
Panafina, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Acute Pancreatitis

United States
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Netherlands
Amgen

Terminated

Phase 2 Study of AMG 337 in MET Amplified Gastric/Esophageal Adenocarcinoma or Other Solid Tumors

Stomach Neoplasms

Belgium, France, Italy, Spain, Czechia, Poland, United States, Korea, Republic of, Russian Federation, Canada, United Kingdom, Australia, Austria, Germany, Hungary, Greece, Peru, Chile
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

Respiratory Syncytial Virus Infections | Drug Safety

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating TTI-237 in Advanced Malignant Solid Tumors

Neoplasms

United States
Takeda

Completed

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy Participants

Dose Finding Study
T3 Pharmaceuticals AG

Recruiting

First in Human Study of T3P-Y058-739 (T3P)

Advanced Solid Tumor

United Kingdom, Switzerland
Kallyope Inc.

Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

Obesity | Type 2 Diabetes Mellitus (T2DM)

United States
Kallyope Inc.

Completed

A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833

Obesity

United States
Zoll Medical Corporation

Enrolling by invitation

Pre-hospital Ventilation Clinical Study

Heart Failure | Sepsis | Hemorrhage | Cardiac Arrest | Respiratory Distress Syndrome, Adult | Altered Mental Status

United States
Vertex Pharmaceuticals Incorporated

Completed

A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza Virus

Influenza Virus

United Kingdom
Maastricht Radiation Oncology
Maastricht University Medical Center

Withdrawn

Non-invasive Imaging With [18F]VM4-037 ([18F]VM4-037)

Stage 4 Cancer
MicroDose Therapeutx, Inc

Completed

A Trial to Assess the Safety, Tolerability and Pharmacokinetics of MDT-637 in Subjects With Intermittent, or Mild-to-Moderate Persistent, Asthma

Drug Safety

United States
CardioKinetix, Inc

Completed

Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients (PARACHUTE)

Heart Failure

United States, Serbia
Kallyope Inc.

Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes

Obesity | Type 2 Diabetes Mellitus in Obese

United States

Search clinical trials for: VPD-737

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Indonesia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations